| 摘要 |
<p>The invention concerns the use of Ginkgo biloba extracts, and in particular Ginkgo biloba extracts containing 20 to 30 % of flavoneglycosides, 2.5 to 4.5 % of ginkgolides A, B, C and J, 2 to 4 % of bilobalide, less than 10 % of proanthocyanidines and less than 10 ppm of compounds of the alkylphenol type, for preparing a medicine for treating amyotrophic lateral sclerosis.</p> |
